Celon Pharma (LTS:0RKX) Other Operating Expense: zł124.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RKX Celon Pharma SA LTS:0RKX
21 GF Score
Price zł22.50
! 3 Warning Signs
View Full Analysis

What is Celon Pharma Other Operating Expense?

Celon Pharma LTS:0RKX 21 Other Operating Expense is zł124.8 Mil as of Mar. 2026. GuruFocus rates LTS:0RKX with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Celon Pharma's Other Operating Expense for the three months ended in Mar. 2026 was zł46.8 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was zł124.8 Mil.

Celon Pharma's quarterly Other Operating Expense declined from Sep. 2025 (zł29.7 Mil) to Dec. 2025 (zł0.0 Mil) but then increased from Dec. 2025 (zł0.0 Mil) to Mar. 2026 (zł46.8 Mil).

Celon Pharma's annual Other Operating Expense increased from Dec. 2023 (zł128.6 Mil) to Dec. 2024 (zł151.2 Mil) but then declined from Dec. 2024 (zł151.2 Mil) to Dec. 2025 (zł0.0 Mil).

Celon Pharma Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Celon Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celon Pharma Other Operating Expense Chart

Celon Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.45 133.46 128.57 151.19 0.00

Celon Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.90 48.26 29.74 0.00 46.78
LTS:0RKX
21GF Score
Celon Pharma SA LTS:0RKX
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celon Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł124.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of zł124.8 Mil mean?
Celon Pharma (LTS:0RKX) has a Other Operating Expense of zł124.8 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Celon Pharma and its competitors.
Is Celon Pharma's Other Operating Expense too high?
Celon Pharma's current Other Operating Expense is zł124.8 Mil. Overall, Celon Pharma has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Celon Pharma's Other Operating Expense compare to ZTS and UTHR?
Celon Pharma's Other Operating Expense of zł124.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Celon Pharma and its competitors. Celon Pharma's current Other Operating Expense is zł124.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celon Pharma stock overvalued right now?
Celon Pharma (LTS:0RKX) has a current Other Operating Expense of zł124.8 Mil. The current Other Operating Expense is zł124.8 Mil. Celon Pharma's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Celon Pharma (LTS:0RKX), the current Other Operating Expense is zł124.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Celon Pharma Business Description

Other Exchanges CLN:Poland8RP:Germany
Address Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092
Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.
21GF Score

Get the complete analysis for LTS:0RKX

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł22.50
Price